Efficacy and safety evaluation of sucrose-formulated recombinant factor VIII for Taiwanese patients with haemophilia A.
Young
J-H
JH
Liu
H-C
HC
Hsueh
E-J
EJ
Huang
M-L
ML
Peng
C-T
CT
Chen
R-L
RL
Maas-Enriquez
M
M
Achilles
K
K
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003029:Coagulants / Q000627:therapeutic use*; D005169:Factor VIII / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011358:Product Surveillance, Postmarketing; D013395:Sucrose / Q000627:therapeutic use*; D013624:Taiwan; D016896:Treatment Outcome; D055815:Young Adult
D003029:Coagulants; C438308:recombinant FVIII, sugar formulated; D013395:Sucrose; D005169:Factor VIII